Contribution: Industrial Research Assistance Program – Contributions to Firms
Laboratoires Pharma in silica inc.
$75,000.00
ARP - Feasibility - Development of new applications for the Opkemo nanomedicine platform.
FY 2023-24 · 2023-12-04
Summary
Development of new silica-based nanovector formulations for sustained release of active pharmaceutical ingredients, similar to metronomic chemotherapy.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
743257313
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2024-10-31
Agreement Number
1012956
Agreement Start Date
2023-12-04
Agreement Title
ARP - Feasibility - Development of new applications for the Opkemo nanomedicine platform.
Agreement Title (French)
PRA - Faisabilité - Développement de nouvelles applications pour la plateforme de nanomédecine Opkemo.
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of new silica-based nanovector formulations for sustained release of active pharmaceutical ingredients, similar to metronomic chemotherapy.
Description (French)
Développement de nouvelles formulations du nanovecteur à base de silice permettant la libération prolongée d’actifs pharmaceutiques de façon similaire à la chimiothérapie métronomique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Québec
Federal Riding (French)
Québec
Federal Riding Number
24059
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
743257313
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Laboratoires Pharma in silica inc.
Recipient Operating Name
Pharma in silica
Recipient Postal Code
G1P 4S6
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2023-2024-Q3-1012956
